Great Point Partners’s Myovant Sciences Ltd. MYOV Stock Holding History

Great Point Partners’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-325,000	Closed	-$1.69M	–	53
2019 Q3	$1.69M	Buy	+325,000	New	+$2.41M	0.16%	39
2018 Q1	–	Sell	-160,530	Closed	-$2.03M	–	48
2017 Q4	$2.03M	Sell	160,530 -67,478	-30%	-$905K	0.35%	35
2017 Q3	$3.53M	Sell	228,008 -19,891	-8%	-$242K	0.69%	31
2017 Q2	$2.9M	Sell	247,899 -159,660	-39%	-$1.98M	0.52%	32
2017 Q1	$4.79M	Buy	407,559 +57,559	+16%	+$660K	0.95%	27
2016 Q4	$4.35M	Buy	+350,000	New	+$4.06M	0.89%	24

Other funds holding MYOV

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

NCM

NovaQuest Capital Management Raleigh, North Carolina $54.3M AUM 163.39% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Great Point Partners's MYOV Position: Q4 2019 in Review

Great Point Partners sold out of Myovant Sciences Ltd. (MYOV) in Q4 2019, closing a stake of 325,000 shares — an estimated $1.69M sold.

Great Point Partners first reported a position in MYOV in Q4 2016 and held it in 6 quarters. The position peaked at $4.79M in Q1 2017. 77 funds tracked by Wall St. Rank hold MYOV as of Q4 2019.

Great Point Partners reported no remaining Myovant Sciences Ltd. position as of Q4 2019 after selling out during the quarter.
Great Point Partners sold 325,000 Myovant Sciences Ltd. shares in Q4 2019, an estimated $1.69M.
Great Point Partners first reported a position in Myovant Sciences Ltd. in Q4 2016 and held it in 6 quarters.
Great Point Partners's Myovant Sciences Ltd. position peaked at $4.79M in Q1 2017.
77 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2019.

Based on Great Point Partners's 13F filing for Q4 2019, filed 14 Feb 2020.